Endocyte (ECYT) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts ECYT Hot Sheet
Join SI Premium – FREE
Endocyte (NASDAQ: ECYT) reported Q2 EPS of ($0.28), $0.03 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Endocyte (ECYT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Tesla to launch Cybercab in Austin this month - report
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
